Laurent Gressot

Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy

Frances A. Shepherd, Janet Dancey, Rodryg Ramlau, K. Mattson et autres

us (code pays fourni par la source)

Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial

Meletios Α. Dimopoulos, Paul G. Richardson, Nizar J. Bahlis, Sebastian Grosicki et autres

gr, us, ca, pl, it, tr, de, il, es, cz (code pays fourni par la source)

Nanoparticle Albumin-bound Paclitaxel Plus Carboplatin Induction Followed by Nanoparticle Albumin-bound Paclitaxel Maintenance in Squamous Non–Small-cell Lung Cancer (ABOUND.sqm): A Phase III Randomized Clinical Trial

David R. Spigel, Robert M. Jotte, Santiago Ponce Aix, Laurent Gressot et autres

us, es, de, it (code pays fourni par la source)

MA13.05 Nab-Paclitaxel Maintenance in Squamous Non-Small Cell Lung Cancer (NSCLC): Updated Results of the Phase III ABOUND.sqm Study

David R. Spigel, Robert M. Jotte, Santiago Ponce Aix, Laurent Gressot et autres

us, es, it (code pays fourni par la source)

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

Paul G. Richardson, Albert Oriol, Meral Beksaç, Anna Marina Liberati et autres

us, es, tr, it, no, gb, de, ca, fr, jp, ie, nl, pl, ru, ch, gr (code pays fourni par la source)

nab-paclitaxel + carboplatin induction followed by nab-paclitaxel maintenance in squamous non-small cell lung cancer (NSCLC): Results from the ABOUND.sqm study

David R. Spigel, Robert M. Jotte, Santiago Ponce Aix, Laurent Gressot et autres

us, es, it, de (code pays fourni par la source)

nab-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy

Michael Thomas, David R. Spigel, Robert M. Jotte, Michael McCleod et autres

de, us, es, it (code pays fourni par la source)

P2.03a-030 nab-Paclitaxel/Carboplatin Induction Therapy in Squamous (SCC) NSCLC: Interim Quality of Life (QoL) Results From ABOUND.sqm

Michael Thomas, Ray D. Page, Laurent Gressot, Davey B. Daniel et autres

de, us, es (code pays fourni par la source)

MINI01.20: Interim Quality of Life (QoL) Results from ABOUND.sqm: nab -Paclitaxel/Carboplatin Induction Therapy in Squamous (SCC) NSCLC

Michael Thomas, Ray D. Page, Laurent Gressot, Davey B. Daniel et autres

de, us, es (code pays fourni par la source)

Sunitinib Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel for First-Line Treatment of Patients With Advanced Breast Cancer: A Phase III, Randomized, Open-Label Trial

Nicholas J. Robert, Mansoor N. Saleh, Devchand Paul, Daniele Generali et autres

us (code pays fourni par la source)

Prospective R andomized T rial o f D ocetaxel V ersus B est Supportive C are i n P atients W ith N on-Small-Cell L ung Cancer P reviously T reated W ith P latinum-Based Chemotherapy

Frances A. Shepherd, Janet Dancey, Rodryg Ramlau, K. Mattson et autres

Concurrent chemotherapy and “concomitant boost” radiotherapy for unresectable head and neck cancer

Bin S. Teh, Uma Monga, Jack Thornby, Laurent Gressot et autres

us (code pays fourni par la source)